MENU
 JPMA
  • Access
  • Japanese
  • About JPMA

    About JPMA Top

    • Top Message
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • Newsletter
  • Newsroom

    Newsroom Top

    • News Releases and Notices
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video contents and advertisements
  • The Office of Pharmaceutical Industry Research
Close
 JPMA

Return to Site Top

  • For Patients and the Public (About Pharmaceuticals)
    For Patients and the Public (About Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Promotion Committee
    • Industry Policy Committee
    • Distribution Appropriateness Committee
    • Drug Evaluation Committee
    • Quality Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • Research and Development Committee
    • International Committee
    • Public Relations Committee
    • Patient Organization Collaboration Promotion Committee
    • ICH Project
    • APAC Project
    • Pharmaceutical Counseling and Response Review Committee
    • Environmental Issues Review Committee
  • About JPMA
    About JPMA Top
    • Top Message
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • JPMA Code of Practice
    • Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions
    • Transparency Guidelines for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries, etc. for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Principles and Action Guidelines on Biodiversity
    • Guidelines for Proper Competition at Japan Pharmaceutical Manufacturers Association Meetings
    • Guideline for the Promotion of the Industry Vision 2035
  • Newsroom
    Newsroom Top
    • News Releases and Notices
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video contents and advertisements
  • The Office of Pharmaceutical Industry Research Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Access
  • Japanese
  • Top
  • Policies and Activities
  • Business Policy, Business Plan, Implementation Plan

Business Policy, Business Plan, Implementation Plan

FY 2026 Business Policy and Business Plan

FY 2026 Business Policy and Business Plan

FY 2026 Implementation Plan

  • 1. Code Compliance Committee
  • 2. Pharmaceutical Industrial Policy Committee
  • 3. Distribution Improvement Committee
  • 4. Drug Evaluation Committee
  • 5. ICH Project
  • 6. Quality & Technology Committee
  • 7. Biopharmaceutical Committee
  • 8. Regulatory Affairs Committee
  • 9. Intellectual Property Committee
  • 10. R & D Committee
  • 11. International Affairs Committee
  • 12. Public Affairs Committee
  • 13. Patient Cooperation Committee
  • 14. Review Board of Ethical Drug Product Information Brochure
  • 15. Consumer Consultation Review Committee
  • 16. Environmental Issue Committee
  • 17. The Office of Pharmaceutical Industry Research
  • 18. Secretariat

Share this page

  • Post
  • Share

TOP

Site Search

  • Top
  • Policies and Activities
  • Business Policy, Business Plan, Implementation Plan
  • JPMA PR and Communication Activities
  • Pharmaceutical Research Institute
  • List of Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • About JPMA
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • Newsroom
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • JapanesePage will open in a new window.
  •  x
  •  facebook
  •  youtube
  • Site Map
  • Website Terms of Use
  • Basic Policy on Information Security
  • Social Media Policy
  • Links
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).All rights reserved.

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.